"Stroke", "brain attack", and "ischemic attack" are interchangeable terms used for an interruption of the blood supply to the brain.

Warning signs are:
1. Sudden numbness or weakness of face, arm or leg, especially on one side of the body.

2. Sudden confusion, trouble speaking or understanding.

3. Sudden vision difficulty in one or both eyes.

4. Sudden difficulty walking, dizziness, loss of balance or coordination.

5. Sudden severe headache, with no known cause.



CIS Biotech, Inc. has developed laboratory tests for the early detection of stroke and, in collaboration with DeKalb Medical Center (Decatur, Georgia, USA), is making its "home brew" in-house assays available for screening people with conditions that place them at a higher risk for stroke, such as diabetes mellitus, atherosclerosis, hypertension, and cardiovascular disease.

These tests are among the first that can predict acute neurological events outside of a research setting. The is affordable, fast and minimally invasive, requiring only a small sample of venous blood. People with abnormal biomarker levels will be urged to visit their physicians for further testing to determine their risk for stroke.

Both tests have CE mark and can be sold for research use only in the USA.

CIS Biotech, Inc has a CLIA certificate and Georgia State License for Gold Dot NR2 Peptide test and Gold Dot NR2 Antibody test. We can perform the testing at our facility for in and out of state patients if they are referred by authorized physician (the request paperwork will be provided upon your request) and if your state does not have any additional certification requirements for out of state sample shipment and analysis. For further information please fill out the contact form and we will get in touch with you as soon as possible. Thank You!